Enovis Set to Maintain Double-Digit Recon Growth in 2024

Enovis reported 4Q23 orthopedic sales of $189.7 million, +16.7% compared to the fourth quarter of 2022. For 2023, the company generated $694.5 million in orthopedic sales and grew +15.9% compared to the prior year.

The company expanded its recon platform with total organic growth of +14%, double-digit organic growth across all major...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us